Supplements may protect those with low vitamin D levels from severe COVID-19 补充剂可以保护维生素D水平低的人免受严重COVID-19的侵害

News Release 20-Mar-2021

Editor’s note: This study indicates that hospitalized covid 19 patients are at higher risk of death if their serum vitamin D levels are low. It also fins that more than half of these low vitamin D patients do not receive vitamin D supplements, and if they receive even as low as 1000 units per week, their risk of drying from covid 19 can be significantly reduced.

Numerous studies have demonstrated the importance of vitamin D in human immunity against all bacterial/viral infections including covid 19 infection.

More reports on vitamin D.

编者注：这项研究表明，住院的covid 19病人如果血清维生素D水平较低，则有较高的死亡风险。 还发现，这些低维生素D患者中有超过一半的人不接受维生素D补充剂，如果他们每周接受低至1000单位的维生素D补充剂，则可以大大降低他们从covid 19中干燥的风险。

大量研究表明，维生素D在抵抗所有细菌/病毒感染（包括covid 19感染）的人类免疫中的重要性。

Study finds more than half of patients with low vitamin D do not receive supplements

The Endocrine Society

WASHINGTON–Patients with low vitamin D levels who are hospitalized for COVID-19 may have a lower risk of dying or requiring mechanical ventilation if they receive vitamin D supplementation of at least 1,000 units weekly, according to a study presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.

“Given how common vitamin D deficiency is in the world and the United States, we believe that this research is highly relevant right now,” said co-author Sweta Chekuri, M.D., of Montefiore Health System and Albert Einstein College of Medicine in the Bronx, New York.

Research has shown that vitamin D supplementation can prevent inflammation in other respiratory diseases, but there have been limited studies examining the role of vitamin D supplementation in COVID-19. The purpose of the study was to determine whether being supplemented with vitamin D before being admitted to the hospital with COVID-19 resulted in less severe COVID-19 disease in patients with a low vitamin D level.

The researchers studied 124 adult patients with low vitamin D that was measured up to 90 days before their admission for COVID-19. They compared the patients who were supplemented with at least 1,000 units of vitamin D weekly to those who had not received vitamin D supplements in terms of whether they were mechanically ventilated or died during admission.

They found that patients who were supplemented were less likely to be mechanically ventilated or to die following admission, though the finding wasn’t statistically significant (37.5 percent of patients who were not supplemented vs. 33.3 percent of those who were) They also found that more than half of those who should have been supplemented were not.

“Though we weren’t able to show a definitive link to severe COVID-19, it is clear that patients with low vitamin D should receive supplementation not only for bone health, but also for stronger protection against severe COVID-19,” said co-author Corinne Levitus, D.O., of Montefiore Health System and Albert Einstein College of Medicine. “We hope this research will encourage clinicians to discuss adding this supplement with their patients who have low vitamin D, as this may reduce the odds of people developing severe COVID-19.”

A study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism last fall found over 80 percent of 200 COVID-19 patients in a hospital in Spain had vitamin D deficiency.

###

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.